MedPath

Evaluation of the efficacy of narrow band imaging with magnifying colonoscopy for the diagnosis of dysplasia.

Phase 2
Completed
Conditions
Colorectal neoplasm
Registration Number
JPRN-UMIN000003740
Lead Sponsor
Osaka Medical Center for Cancer and Cardiovascular Diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
550
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who had previously undergone histological examination. 2)Patients with open bleeding or symptoms suspected colonic stenosis. 3)Patients with inflammatory bowel disease, familial polyposis and known colon neoplasm. 4)Patients who are receiving anticoaglant medication or having bleeding tendency. 5)Patients with severe organ failure. 6)Patients without informed consent. 7)Patients who are regarded in-eligible by the doctor who participates in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Specificity of NBI-ME in accurate decision for low grade dysplasia.
Secondary Outcome Measures
NameTimeMethod
Procedure time (insertion and observation), Diagnostic ability (sensitivity, specificity and accuracy) for high grade dysplasia, low grade dysplasia and non-neoplastic lesion using NBI-nonME and NBI-ME, Accurate clinical decision rate (resect and discard, resect and send and leave it in situ) using NBI-nonME and NBI-ME. Diagnostic accuracy according to the lesion size (<5mm, >6mm). Adverse events.
© Copyright 2025. All Rights Reserved by MedPath